Pinteon Therapeutics Overview
Founded
2014
Status
Private
Employees
6
Latest Deal Type
Series A
Latest Deal Amount
$17M
Investors
1
Pinteon Therapeutics General Information
Description
Developer of novel antibody designed to maintain brain health of the patients. The company's antibody interrupts the spread of toxic tau and protect and preserve brain function in patients who suffers from neurodegenerative disease, enabling researchers to normalize aberrant disease processes and improve patient outcomes in these high unmet medical need indications.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Drug Delivery
Pharmaceuticals
Primary Office
- 1188 Centre Street
- Newton Centre
- Newton, MA 02459
- United States
+1 (917) 000-0000
Pinteon Therapeutics Timeline
Pinteon Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 31-Oct-2019 | $17M | 0000 | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC (Series A) | 17-Aug-2017 | 0000 | 0000 | 000.00 | Completed | Generating Revenue |
Pinteon Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Pinteon Therapeutics Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Martin Jefson Ph.D | Chief Executive Officer | ||
| Michael Ahlijanian Ph.D | Chief Scientific Officer | ||
| Larry Altstiel MD | Chief Medical Officer |
1 Former Executive
Pinteon Therapeutics Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jason Dinges Ph.D | Morningside Group | Board Member | 000 0000 |
| Jeffrey Ives Ph.D | Self | Chairman | 000 0000 |
| Westley Nolin Ph.D | Self | Board Member | 000 0000 |
Pinteon Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Morningside Group | Venture Capital | Minority | 000 0000 | 000000 0 |
Ready to get started?
Request a free trial